Valuation: Mesa Laboratories, Inc.

Market Cap 698M 598M 560M 512M 961M 66.8B 974M 6.61B 2.58B 33.56B 2.62B 2.56B 111B P/E 2027 *
56.5x
P/E 2028 * 37.4x
Enterprise Value 698M 598M 560M 512M 961M 66.8B 974M 6.61B 2.58B 33.56B 2.62B 2.56B 111B EV / Sales 2027 *
2.73x
EV / Sales 2028 * 2.58x
Free-Float
94.38%
Yield 2027 *
0.51%
Yield 2028 * 0.51%
1 day+4.71%
1 week+17.65%
Current month+23.76%
1 month+26.57%
3 months+14.84%
6 months+33.63%
Current year+58.93%
1 week 103.94
Extreme 103.94
124.89
1 month 93.03
Extreme 93.03
124.89
Current year 71.06
Extreme 71.065
124.89
1 year 58.83
Extreme 58.8337
124.89
3 years 55.45
Extreme 55.45
155.12
5 years 55.45
Extreme 55.45
333.42
10 years 55.45
Extreme 55.45
333.42
Manager TitleAgeSince
Chief Executive Officer 57 2026-04-11
Director of Finance/CFO 58 2012-10-28
Comptroller/Controller/Auditor 41 2021-12-31
Director TitleAgeSince
Chairman 73 2017-08-31
Director/Board Member 58 2019-03-03
Director/Board Member 57 2020-05-10
Date Insider Type Main position Quantity % Market Cap.
8/15/26 Fiscal year

Director

5,568 0.0995%
8/15/26 Fiscal year

Director

5,568 0.0995%
8/15/26 Fiscal year

Chairman

5,568 0.0995%
Change 5-day change 1-year change 3-year change Capi.($)
+4.71%+17.65%+71.00%-9.86% 698M
+2.19%+4.84%-12.03%+10.93% 202B
+1.14%+2.28%+0.69%+11.50% 119B
+1.06%+1.34%+8.69%+78.71% 60.69B
-1.37%-6.57%+30.31%+55.01% 52.38B
+2.33%+4.69%-3.84%-30.36% 52.3B
+2.35%+2.89%+12.25%-13.68% 34.85B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+42.46%-10.20% 24.85B
-0.29%-3.87%-6.19%+25.59% 23.84B
Average +1.71%+2.02%+15.93%+13.07% 60.1B
Weighted average by Cap. +1.53%+1.92%+1.67%+16.68%

Financials

2027 *2028 *
Net sales 255M 219M 205M 187M 352M 24.43B 356M 2.42B 943M 12.27B 959M 938M 40.59B 270M 232M 217M 198M 372M 25.86B 377M 2.56B 998M 12.99B 1.01B 993M 42.97B
Net income 13.27M 11.36M 10.63M 9.73M 18.27M 1.27B 18.51M 126M 48.99M 638M 49.82M 48.73M 2.11B 21.13M 18.1M 16.94M 15.51M 29.1M 2.02B 29.48M 200M 78.04M 1.02B 79.35M 77.63M 3.36B
Net Debt - -
Logo Mesa Laboratories, Inc.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Employees
717
Date Price Change Volume
26-08-21 $124.76 +4.71% 160,693
26-08-20 $119.15 -0.48% 185,385
26-08-19 $119.72 +10.91% 236,472
26-08-18 $107.94 +0.28% 194,223
26-08-17 $107.64 +1.51% 139,567
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
124.76USD
Average target price
117.50USD
Spread / Average Target
-5.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MLAB Stock